A detailed history of Zwj Investment Counsel Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zwj Investment Counsel Inc holds 18,393 shares of BMY stock, worth $1.06 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,393
Previous 20,607 10.74%
Holding current value
$1.06 Million
Previous $855,000 11.23%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$39.66 - $51.75 $87,807 - $114,574
-2,214 Reduced 10.74%
18,393 $951,000
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $16,583 - $21,831
412 Added 2.04%
20,607 $855,000
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $1,583 - $1,795
-33 Reduced 0.16%
20,195 $1.1 Million
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $8,241 - $9,834
-170 Reduced 0.83%
20,228 $1.04 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $15,109 - $16,894
-261 Reduced 1.26%
20,398 $1.18 Million
Q2 2023

Jul 13, 2023

SELL
$63.71 - $70.74 $35,040 - $38,907
-550 Reduced 2.59%
20,659 $1.32 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $18,661 - $21,166
-284 Reduced 1.32%
21,209 $1.47 Million
Q4 2022

Jan 24, 2023

BUY
$68.48 - $81.09 $1,712 - $2,027
25 Added 0.12%
21,493 $0
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $307,327 - $338,475
4,232 Added 24.55%
21,468 $1.65 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $6,148 - $7,372
-100 Reduced 0.58%
17,236 $1.26 Million
Q4 2021

Mar 31, 2022

SELL
$53.63 - $62.52 $75,082 - $87,528
-1,400 Reduced 7.47%
17,336 $1.08 Million
Q2 2021

Mar 31, 2022

SELL
$61.91 - $67.42 $227,209 - $247,431
-3,670 Reduced 16.38%
18,736 $1.25 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $3.08 Million - $3.46 Million
-51,851 Reduced 69.83%
22,406 $1.41 Million
Q4 2020

Feb 26, 2021

BUY
$57.74 - $65.43 $66,227 - $75,048
1,147 Added 1.57%
74,257 $4.61 Million
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $192,677 - $213,512
-3,355 Reduced 4.39%
73,110 $4.41 Million
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $6.89 Million - $8.06 Million
-125,694 Reduced 62.18%
76,465 $4.5 Million
Q1 2020

May 18, 2020

SELL
$46.4 - $67.43 $192,884 - $280,306
-4,157 Reduced 2.01%
202,159 $11.3 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $9.47 Million - $12.4 Million
192,528 Added 1396.34%
206,316 $13.2 Million
Q3 2019

Oct 22, 2019

BUY
$42.77 - $50.71 $52,350 - $62,069
1,224 Added 9.74%
13,788 $699,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $14,099 - $15,591
-316 Reduced 2.45%
12,564 $570,000
Q1 2019

May 21, 2019

SELL
$45.12 - $53.8 $103,595 - $123,524
-2,296 Reduced 15.13%
12,880 $615,000
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $156,470 - $202,905
3,209 Added 26.82%
15,176 $789,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $13,411 - $15,126
-243 Reduced 1.99%
11,967 $743,000
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $25,265 - $31,490
-500 Reduced 3.93%
12,210 $676,000
Q1 2018

Apr 24, 2018

BUY
$59.92 - $68.98 $26,604 - $30,627
444 Added 3.62%
12,710 $804,000
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $677,451 - $781,834
12,266
12,266 $782,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Zwj Investment Counsel Inc Portfolio

Follow Zwj Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Zwj Investment Counsel Inc with notifications on news.